Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cancers: Mechanisms and Therapeutic Strategies
Journal of Cancer · 03.09.2026 · 17 (9) · 1600-1614
DOI: 10.7150/jca.130206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cancer, erschienen am 03.09.2026. Verfasst von Jiahui Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhangjiagang TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, 215600, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Zhangjiagang TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, 215600, China.
- School of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, China.
- Department of Pharmacy, Taicang TCM Hospital, Affiliated to Nanjing University of Chinese Medicine, Taicang, Jiangsu, 215400, China.
Zitieren
APA
Guo, J., Wang, Y., Li, J., & Jiang, Z. (2026). Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cancers: Mechanisms and Therapeutic Strategies. Journal of Cancer, 17(9), 1600-1614. https://doi.org/10.7150/jca.130206
Vancouver
Guo J, Wang Y, Li J, Jiang Z. Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cancers: Mechanisms and Therapeutic Strategies. Journal of Cancer. 2026;17(9):1600-1614. doi:10.7150/jca.130206
BibTeX
@article{Guo2026,
author = {Guo, Jiahui and Wang, Yilei and Li, Jie and Jiang, Zhitao},
title = {Overcoming Resistance to PARP Inhibitors in BRCA-Mutated Cancers: Mechanisms and Therapeutic Strategies},
journal = {Journal of Cancer},
year = {2026},
volume = {17},
number = {9},
pages = {1600--1614},
doi = {10.7150/jca.130206}
}
EUVIMED